A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2002
11/20/2002	CN1380107A DNA tumor vaccine and its preparation method
11/19/2002	US6482929 Antibodies to ARF-p19
11/19/2002	US6482927 Chimeric proteins comprising the extracellular domain of murine Ob receptor
11/19/2002	US6482922 Mammary transforming protein
11/19/2002	US6482804 Compositions and methods for delivery of genetic material
11/19/2002	US6482803 Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A
11/19/2002	US6482795 Tumor suppressor designated TS10q23.3
11/19/2002	US6482633 Accessory functions for use in recombinant AAV virion production
11/19/2002	US6482623 Lipid kinase
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482617 Viable contaminant particle free adenoviruses, their preparation and use
11/19/2002	US6482616 RCA-free adenoviral vector system and propagation method
11/19/2002	US6482599 Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
11/19/2002	US6482598 Antibody recognizing a small subset of human hematopoietic cells
11/19/2002	US6482586 Hybrid compositions for intracellular targeting
11/19/2002	US6482416 Alteration of macrophage-induced t cell suppression or concentration by the selective elimination or increase of tryptophan by administering an enzyme inhibitor of indole-amino 2,3-deoxygenase; viricides; abortion; fertility;
11/19/2002	US6482408 Fibroblast growth factor 15 antibodies
11/19/2002	US6482407 Membrane-bound cytokine compositions comprising GM-CSF or an active fragment thereof and methods of modulating and an immune response using the same
11/19/2002	US6482406 Cell-based gene therapy for the pulmonary system
11/19/2002	US6482405 Antitumor
11/19/2002	US6482403 Caniney IL-13 immunoregulatory proteins and uses thereof
11/19/2002	US6481065 Jewelry closure
11/19/2002	CA2156512C Treatment of androgen-associated baldness using antisense oligomers
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/14/2002	WO2002090974A2 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090590A1 Antisense modulation of interleukin 12 p35 subunit expression
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090558A1 Novel expression vectors and uses thereof
11/14/2002	WO2002090555A1 A method for transfection of rna using electrical pulses
11/14/2002	WO2002090551A2 Self-containing lactococcus strain
11/14/2002	WO2002090545A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090514A2 Epidermal growth factor receptorantisense oligonucleotides
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090501A2 Vectors having replication, immunogenicity and/or pathogenicity under stress promoter regulation and use thereof
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090382A2 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	WO2002090329A1 Cationic amphiphiles as transfection vehicles
11/14/2002	WO2002089857A2 Trans-viral vector mediated gene transfer to the retina
11/14/2002	WO2002089856A1 Techniques and compositions for treating cardiovascular disease by (in vivo) gene delivery
11/14/2002	WO2002089855A1 Peroral transduction of hepatocytes in the treatment of disease
11/14/2002	WO2002089854A1 Gene transfer of angiogenic factor for skin disease
11/14/2002	WO2002089840A1 Recombinant bicistronic flaviviruses and methods of use thereof
11/14/2002	WO2002089832A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	WO2002089817A2 Anti-virus agent
11/14/2002	WO2002089727A2 Methods of using cytokine c17
11/14/2002	WO2002089658A2 Microvascular free flaps for local or systemic delivery
11/14/2002	WO2002089581A1 Antimicrobial compounds and methods for their use
11/14/2002	WO2002078439A3 Prevascularized constructs for implantation to provide blood perfusion
11/14/2002	WO2002068465A9 Novel p53-inducible protein
11/14/2002	WO2002061081A9 A novel gene bn01 mapping to chromosome 16q24.3
11/14/2002	WO2002056918A3 Method of enhancing delivery of a therapeutic nucleic acid
11/14/2002	WO2002049422A3 Non-human animal disease models
11/14/2002	WO2002040635A3 HUMAN RNase H1 MUTANTS
11/14/2002	WO2002028906A3 Regulation of human sphingosine kinase-like protein
11/14/2002	WO2001031036A9 Modified viral surface proteins which bind to cells of tumor vasculature
11/14/2002	WO2001011009A9 Intestinal gene therapy
11/14/2002	US20020169306 Paramyxoviral vectro for use as diagnostic tools in genetic engineering
11/14/2002	US20020169301 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders
11/14/2002	US20020169287 Nucleotide sequences coding polypeptide for use in the treatment of eating, dieteticad energy disorders
11/14/2002	US20020169284 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system, virus, and visoin disorders
11/14/2002	US20020169139 Single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof
11/14/2002	US20020169137 Preventing or inhibiting pathological beta-amyloid plaque formation in conditions such as Alzheimer's disease
11/14/2002	US20020169132 Polypeptides
11/14/2002	US20020169131 TGF-alpha polypeptides, functional fragments and methods of use therefor
11/14/2002	US20020169126 E1A gene based anti-cancer therapy that targets cancers and tumors involving phospho-Akt expression (and/or Akt activation) and/or phospho-p38 downregulation (and/ or p38 inactivation)
11/14/2002	US20020168771 Expression vcetor for use as tool in genetic engineering
11/14/2002	US20020168763 Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
11/14/2002	US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders
11/14/2002	US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002	US20020168724 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168711 Nucleic acids, proteins, and antibodies
11/14/2002	US20020168709 Adjustment of gene expression
11/14/2002	US20020168695 Detecting cell proliferative disorder in humans; obtain tissue sample, incubate with probe, detect signal from tissue sample, signal indicates cancer
11/14/2002	US20020168675 Nucleotide sequences for use in the diagnosis and treatment of psychological disorders
11/14/2002	US20020168672 Nucleotide sequences coding proteins for use in the treatment of tumors
11/14/2002	US20020168669 Patterned polymer synthesis
11/14/2002	US20020168650 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/14/2002	US20020168633 Nucleotide fragment of the 23s rna of the genus chlamydia, use as a probe, primer, and in a reagent and a detection procedure
11/14/2002	US20020168385 Adeno-associated virus vector for boosting immunogenicity of cells
11/14/2002	US20020168384 Vaccine for poultry respiratory disorders
11/14/2002	US20020168371 Process for reducing antibody response against xenografts
11/14/2002	US20020168364 Methods and compositions for modulating tumor growth
11/14/2002	US20020168361 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit
11/14/2002	US20020168349 A viral DNA construct encoding for a virus capable of replication in a human or animal tumor cell and causing death of such tumor cells
11/14/2002	US20020168348 Prolonging the acceptance of a graft by administering a short course of an immunosuppressant
11/14/2002	US20020168346 Contain three vectors which collectively encode retroviral gag, pol, and envelop proteins, and the gag and pol genes are separated, in part, onto two or more different vectors by fusing Vpr or Vpx to pol proteins separated from gag
11/14/2002	US20020168345 Methods of monitoring HIV drug resistance using adenoviral vectors
11/14/2002	US20020168343 Combines transductional targeting via binding to angiotensin converting enzyme expressed on pulmonary endothelial cells with transcriptional targeting using vascular endothelial growth factor type 1 receptor promoter
11/14/2002	US20020168339 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same
11/14/2002	US20020168338 Compositions and methods for delivery of agents for neuronal regeneration and survival
11/14/2002	CA2827671A1 Phosphorus-containing antimicrobial compounds and methods for their use
11/14/2002	CA2447360A1 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	CA2446946A1 Gene transfer of angiogenic factor for skin disease
11/14/2002	CA2446838A1 Novel mutation
11/14/2002	CA2446810A1 Epidermal growth factor receptorantisense oligonucleotides
11/14/2002	CA2446666A1 Method for detecting progredient chronic dementia, and associated peptides and detection reagents

1 ... 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 ... 870